Status:
RECRUITING
Using E-Nose Technology to Measure Response to Treatment in People With Malignant Pleural Mesothelioma
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Collaborating Sponsors:
UNIVERSITY CAMPUS BIO-MEDICO, ITALY
Conditions:
Malignant Pleural Mesothelioma
Eligibility:
All Genders
30-85 years
Phase:
NA
Brief Summary
The researchers are doing this study to test the ability of a new technology called breathprinting, or electronic nose (E-Nose), to measure how people respond to standard treatment for malignant pleur...
Eligibility Criteria
Inclusion
- Aged 30-85 years
- No history of thoracic cancer or extrathoracic cancer potentially involving pleural metastases (i.e., breast, gastric, colon, or pancreas cancer)
- Recent diagnosis of MPM
- Documented, signed, and dated informed consent, obtained before any procedures, for the proposed research study, and signed standard surgical consent for surgical resection
Exclusion
- Aged \<30 or \>85 years at the first outpatient visit
- History of thoracic or extrathoracic cancer that puts the subject at risk for pleural or pulmonary metastases
Key Trial Info
Start Date :
September 8 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2026
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06037941
Start Date
September 8 2023
End Date
September 1 2026
Last Update
September 22 2025
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Memorial Sloan Kettering Basking Ridge (Consent Only)
Basking Ridge, New Jersey, United States, 07920
2
Memorial Sloan Kettering Monmouth (Consent Only)
Middletown, New Jersey, United States, 07748
3
Memorial Sloan Kettering Bergen (Consent Only )
Montvale, New Jersey, United States, 07645
4
Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Consent Only)
Commack, New York, United States, 11725